SCHEMBL6078482

SCHEMBL6078482

O=c1cc(C(F)(F)F)c2cc(NC(=S)NCCc3ccc(Cl)cc3)ccc2o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
LMNA P02545 4/20 0.52
ALOX12 P18054 3/20 0.52
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
PLA2G1B P04054 1/20 0.48
GAA P10253 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 4/20 0.47
ALDH1A1 P00352 3/20 0.47
XBP1 P17861 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
HSP90AA1 P07900 1/20 0.47
AR P10275 1/20 0.45
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
MAP2K1 Q02750 1/20 0.44
CNR1 P21554 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6077812 0.90 MAP2K1 (0.47) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6077590 0.90 KDM4E (0.51) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6076930 0.86 MAP2K1 (0.52) MAPTKMT2AGAANPSR1AR
SCHEMBL6078018 0.84 ALDH1A1 (0.62) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6077798 0.81 RAB9A (0.53) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6077930 0.80 MAPT (0.52) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6078399 0.80 MAPT (0.51) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6077814 0.79 CA9 (0.56) MAPTLMNAMEN1KMT2AHTT
SCHEMBL6077069 0.78 ALDH1A1 (0.55) MAPTLMNAALOX12MEN1KMT2A
SCHEMBL6076379 0.77 MAP2K1 (0.53) MAPTMEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074933-B2 Urea and thiourea derivatives WARNER LAMBERT COMPANY LLC (US) 2006-07-11 US claimed
EP-1603882-A2 UREA AND THIOUREA DERIVATIVES Warner-Lambert Company LLC (US) 2005-12-14 EP claimed
WO-2004072044-A2 UREA AND THIOUREA DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2004-08-26 WO claimed
US-7074933-B2 Urea and thiourea derivatives WARNER LAMBERT COMPANY LLC (US) 2006-07-11 US disclosed
EP-1603882-A2 UREA AND THIOUREA DERIVATIVES Warner-Lambert Company LLC (US) 2005-12-14 EP disclosed
US-20040266820-A1 Urea and thiourea derivatives DU DANIEL Y (US) 2004-12-30 US disclosed
WO-2004072044-A2 UREA AND THIOUREA DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266820-A1 Urea and thiourea derivatives SHBG, ZP1, ZYX MAPT 878/4885LMNA 3406/4885ALOX12 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.